Diagnosis of Anemia In Diffuse Toxic Goitre

Authors

  • Babadzhanova Shaira Agzamovna, Qurbanova Gavhar Chutbayevna, Kurbonova Zumrad Chutbayevna, Nodirzhanova Zulfiaxon Nodirjon qizi Author

DOI:

https://doi.org/10.64149/J.Ver.8.20s.113-119

Keywords:

Diffuse Toxic Goiter, Iron Deficiency Anemia, Megaloblastic Anemia.

Abstract

Diffuse toxic goitre (Graves’ disease) is often accompanied by various hematological changes, including anemia. The diagnosis of anemia in this condition is based on blood count, iron studies, and thyroid function tests. Anemia may result from increased metabolism, iron deficiency, or autoimmune mechanisms. Early detection and treatment are essential for improving the patient’s general condition and prognosis. Anemia was observed in 68.2% of patients with diffuse toxic goiter, of which 28.4% had iron deficiency anemia, 19.6% had megaloblastic anemia, 17.6% had normochromic anemia, and 34.4% had mixed anemia.

Downloads

Published

2025-12-23

How to Cite

Diagnosis of Anemia In Diffuse Toxic Goitre. (2025). Vascular and Endovascular Review, 8(20s), 113-119. https://doi.org/10.64149/J.Ver.8.20s.113-119